What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Diabetes mellitus
- Disease
His primary areas of investigation include Internal medicine, Diabetes mellitus, Cardiology, Type 2 diabetes and Surgery.
His Internal medicine study frequently draws parallels with other fields, such as Endocrinology.
In his work, Troponin is strongly intertwined with Kidney disease, which is a subfield of Diabetes mellitus.
His Cardiology research is multidisciplinary, relying on both Blood pressure and Vascular disease.
His Type 2 diabetes study integrates concerns from other disciplines, such as Metformin, Absolute risk reduction, Albuminuria, Renal function and Intensive care medicine.
His studies deal with areas such as Epidemiology, Cardiac output, Glycated hemoglobin, Type 1 diabetes and Cohort as well as Surgery.
His most cited work include:
- Heart Disease and Stroke Statistics—2013 Update A Report From the American Heart Association (4411 citations)
- Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association (4373 citations)
- Heart Disease and Stroke Statistics—2014 Update A Report From the American Heart Association (4295 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Diabetes mellitus, Cardiology, Type 2 diabetes and Myocardial infarction.
His Internal medicine study combines topics in areas such as Endocrinology and Surgery.
His studies in Diabetes mellitus integrate themes in fields like Randomized controlled trial, Disease, Risk factor and Intensive care medicine.
His study in Cardiology is interdisciplinary in nature, drawing from both Vascular disease and Confidence interval.
The Type 2 diabetes study combines topics in areas such as Metformin and Albuminuria, Kidney disease, Renal function.
The study incorporates disciplines such as Stroke, Cohort and Hazard ratio in addition to Myocardial infarction.
He most often published in these fields:
- Internal medicine (73.96%)
- Diabetes mellitus (45.09%)
- Cardiology (34.15%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (73.96%)
- Diabetes mellitus (45.09%)
- Type 2 diabetes (23.77%)
In recent papers he was focusing on the following fields of study:
Darren K. McGuire mostly deals with Internal medicine, Diabetes mellitus, Type 2 diabetes, Heart failure and In patient.
The concepts of his Internal medicine study are interwoven with issues in Dapagliflozin, Type 2 Diabetes Mellitus and Cardiology.
His work carried out in the field of Diabetes mellitus brings together such families of science as Epidemiology, MEDLINE, Randomized controlled trial, Intensive care medicine and Disease.
His Type 2 diabetes research includes elements of Kidney disease, Renal function, Mace, Proportional hazards model and Hazard ratio.
Darren K. McGuire interconnects Metformin, Sitagliptin, Framingham Risk Score and Biomarker in the investigation of issues within Heart failure.
His Myocardial infarction research incorporates themes from Stroke, Aspirin and Cohort.
Between 2018 and 2021, his most popular works were:
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. (935 citations)
- Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial. (423 citations)
- Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus. (226 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
